Cargando…
HL3501, a Novel Selective A3 Adenosine Receptor Antagonist, Lowers Intraocular Pressure (IOP) in Animal Glaucoma Models
PURPOSE: The A3 adenosine receptor (A3AR) is a known therapeutic target for glaucoma treatment. In this study, we developed HL3501 and examined its selectivity profile and in vitro and in vivo effects. METHODS: For the rabbit model, intraocular pressure (IOP) was increased by laser photocoagulation...
Autores principales: | Kim, Yunhee, Yang, Jaewook, Kim, Jee Young, Lee, Jang Mi, Son, Woo Chan, Moon, Byoung-Gon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883152/ https://www.ncbi.nlm.nih.gov/pubmed/35191964 http://dx.doi.org/10.1167/tvst.11.2.30 |
Ejemplares similares
-
Significance of non-intraocular pressure (IOP)-related factors particularly in normal tension glaucoma: Looking beyond IOP
por: Dinakaran, Shoruba, et al.
Publicado: (2022) -
Reinventing Pedagogy of the Oppressed: Contemporary critical perspectives: James D. Kirylo (Ed.). Bloomsbury Academic, London, 2020, 260 pp. ISBN 978-1-3501-1718-1 (hbk), ISBN 978-1-3501-1717-4 (pbk), ISBN 978-1-3501-1720-4 (ePUB), ISBN 978-1-3501-1719-8 (ePDF)
por: Mojab, Shahrzad
Publicado: (2020) -
Predictors for elevation of Intraocular Pressure (IOP) on glaucoma patients; a retrospective cohort study design
por: Birhanu, Getasew, et al.
Publicado: (2022) -
Detecting IOP Fluctuations in Glaucoma Patients
por: Nuyen, Brenda, et al.
Publicado: (2016) -
The IOP lowering effects of “planning” selective laser trabeculoplasty in open angle glaucoma
por: Chu, Yi-Ching, et al.
Publicado: (2022)